Equities

Biotechnology Assets SA

Biotechnology Assets SA

Actions
  • Price (EUR)0.334
  • Today's Change-0.002 / -0.60%
  • Shares traded63.48k
  • 1 Year change-17.53%
  • Beta1.0279
Data delayed at least 15 minutes, as of May 23 2024 14:01 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Biotechnology Assets SA, formerly known as ADL Bionatur Solutions SA, is a Spain-based biotech company. The Firm’s main activities are: Research, development and production of biotechnological solutions aimed at improving the health and welfare of people and animals; Development, acquisition, transfer and exploitation of industrial and intellectual property rights; Distribution, marketing, export and import of the previously mentioned products. The Company, through its subsidiaries, is also present in Luxembourg, Hong Kong and USA.

  • Revenue in EUR (TTM)3.60m
  • Net income in EUR1.57m
  • Incorporated2005
  • Employees37.00
  • Location
    Biotechnology Assets SAAv. del Desarrollo Tecnologico, 11JEREZ DE LA FRONTERA 11591SpainESP
  • Phone+34 856818424
  • Fax+34 956876851
  • Websitehttps://biatgroup.com/es/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
React Group PLC23.01m58.75k18.99m296.00585.941.878.690.82540.00130.00130.84160.40161.201,593.674.5166,155.410.3064-0.71080.4747-1.1126.7527.260.2553-0.53081.040.77340.0091--43.2442.82107.13--25.65--
11 88 0 Solutions AG56.60m-3.51m19.02m487.00--6.3711.140.336-0.1525-0.15252.570.11392.43--8.71110,120.60-15.09-9.42-35.03-18.3741.4042.31-6.20-4.70---6.780.5655--1.855.86-23.00---28.73--
Kauno energija AB85.05m4.51m19.23m543.009.120.4211.310.22610.10530.10531.992.280.407515.605.22--2.911.553.281.7229.82--7.154.271.1513.790.3772---3.356.76-23.102.4044.42--
Euroconsultants SA5.07m2.06m19.83m40.009.523.869.173.910.13820.13820.34070.34090.5009--2.09126,780.0020.6713.0826.8123.1245.5234.1341.2724.47----0.1676--7.3315.2329.74---9.12--
Merit Group PLC22.62m-3.26m19.84m1.04k--0.526--0.8771-0.1158-0.05560.80381.340.3923--4.0118,478.89-5.65-5.63-7.36-7.7945.2338.66-14.40-13.12--0.38950.151--3.36-2.02-142.95---19.73--
Libero football finance AG50.00k-166.22k20.06m7.00------401.22-0.0042-0.00420.00130.000.1908--0.3648---63.42-22.99-66.09-298.96100.00---332.44-12.57---97.361.00---65.97--99.04------
Biotechnology Assets SA3.60m1.57m21.34m37.0012.332.905.285.930.02730.02730.06240.11580.2053--1.3497,336.228.97-4.0611.15-5.7468.4567.7743.70-58.03--10.020.3773--37.79-31.17180.98---50.70--
Arribatec Group ASA48.95m-2.31m21.60m332.00--0.97911.840.4413-0.3875-0.38758.203.681.0551.414.61---4.97-13.89-8.16-19.4976.6178.02-4.73-14.670.8549-8.180.21--13.47110.0471.92------
Fundusz Hipoteczny Dom SA2.66m-1.21m22.09m12.00--20.39--8.31-0.448-0.4480.98650.40220.2309----945,416.70-10.48-11.23---------45.41-53.84---0.81620.8757--41.7426.0173.10------
Partnera Oyj50.42m-637.96k22.37m102.00--0.48744.780.4436-0.0176-0.01761.391.230.42771.383.07494,345.10-0.8259-1.62-1.35-2.2667.5162.95-1.93-3.661.400.40060.3158---40.9433.6297.36--45.72--
Asmallworld AG21.48m1.55m22.47m--13.236.6110.961.050.11640.11641.640.23321.77--26.47--12.7213.1922.8551.1136.6999.347.208.07----0.55310.0016.9719.275.46--4.61--
All Things Considered Group PLC28.27m-3.46m23.07m134.00--4.12--0.8159-0.2486-0.24862.060.29091.35--6.55179,558.20-17.22---46.24--32.84---12.72--1.10-0.5780.2837--154.72---881.34------
Gielda Praw Majatkowych Vindexus SA28.20m8.61m23.29m122.003.250.36622.660.8262.622.6210.3123.210.342317.499.68--10.436.8811.607.7656.5171.1730.4726.049.499.020.184311.34-7.7912.16-10.5811.2524.391.55
HomeMaid AB (publ)37.89m1.20m23.43m908.0022.286.528.260.61840.73150.731523.032.502.11--13.67484,914.107.219.5117.2425.4685.7185.923.423.81--7.710.599578.407.3211.94-40.57-40.98-21.3320.11
Empresaria Group plc294.10m-3.41m23.43m3.15k--0.54783.020.0797-0.0783-0.07835.030.73022.11--6.3279,460.32-1.100.5837-2.631.4222.9722.46-0.51940.2672--2.440.4479---4.21-7.36-185.29---1.37-12.94
Data as of May 23 2024. Currency figures normalised to Biotechnology Assets SA's reporting currency: Euro EUR

Institutional shareholders

0.12%Per cent of shares held by top holders
HolderShares% Held
GVC Gaesco Gesti�n SGIIC SAas of 31 Mar 202470.45k0.12%
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.